Page 47 - Read Online

ALHulais et al. J Cancer Metastasis Treat 2019;5:3 I http://dx.doi.org/10.20517/2394-4722.2018.71 Page 17 of 23

3. Cortina C, Turon G, Stork D, Hernando-Momblona X, Sevillano M, et al. A genome editing approach to study cancer stem cells in human
tumors. EMBO Mol Med 2017;9:869-79.
4. de Sousa e Melo F, Kurtova AV, Harnoss JM, Kljavin N, Hoeck JD, et al. A distinct role for Lgr5(+) stem cells in primary and metastatic
colon cancer. Nature 2017;543:676-80.
5. Todaro M, Francipane MG, Medema JP, Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010;138:2151-62.
6. Rahman M, Deleyrolle L, Vedam-Mai V, Azari H, Abd-El-Barr M, et al. The cancer stem cell hypothesis: failures and pitfalls. Neurosurgery
2011;68:531-45.
7. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006;355:1253-61.
8. Jones RJ, Matsui W. Cancer stem cells: from bench to bedside. Biol Blood Marrow Transplant 2007;13:47-52.
9. Kim WT, Ryu CJ. Cancer stem cell surface markers on normal stem cells. BMB Rep 2017;50:285-98.
10. Cherciu I, Barbalan A, Pirici D, Margaritescu C, Saftoiu A. Stem cells, colorectal cancer and cancer stem cell markers correlations. Curr
Health Sci J 2014;40:153-61.
11. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, et al. Single-cell cloning of colon cancer stem cells reveals a multi-
lineage differentiation capacity. Proc Natl Acad Sci U S A 2008;105:13427-32.
12. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
13. Dirks PB. Cancer: stem cells and brain tumours. Nature 2006;444:687-8.
14. Richard V, Nair MG, Santhosh Kumar TR, Pillai MR. Side population cells as prototype of chemoresistant, tumor-initiating cells. Biomed
Res Int 2013;2013:517237.
15. Tomita H, Tanaka K, Tanaka T, Hara A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget 2016;7:11018-32.
16. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007;317:337.
17. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
18. Pantel K, Alix-Panabieres C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med 2010;16:398-406.
19. Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature 2013;501:328-37.
20. Poli V, Fagnocchi L, Zippo A. Tumorigenic cell reprogramming and cancer plasticity: interplay between signaling, microenvironment, and
epigenetics. Stem Cells Int 2018;2018:4598195.
21. Batlle E, Clevers H. Cancer stem cells revisited. Nat Med 2017;23:1124-34.
22. Policastro LL, Ibanez IL, Notcovich C, Duran HA, Podhajcer OL. The tumor microenvironment: characterization, redox considerations, and
novel approaches for reactive oxygen species-targeted gene therapy. Antioxid Redox Signal 2013;19:854-95.
23. Ralph SJ, Nozuhur S, Moreno-Sánchez R, Rodríguez-Enríquez S, Pritchard R. NSAID celecoxib: a potent mitochondrial pro-oxidant
cytotoxic agent sensitizing metastatic cancers and cancer stem cells to chemotherapy. J Cancer Metastasis Treat 2018;4:49.
24. Shao Y, Chen T, Zheng X, Yang S, Xu K, et al. Colorectal cancer-derived small extracellular vesicles establish an inflammatory
premetastatic niche in liver metastasis. Carcinogenesis 2018;39:1368-79.
25. Blassl C, Kuhlmann JD, Webers A, Wimberger P, Fehm T, et al. Gene expression profiling of single circulating tumor cells in ovarian cancer
- establishment of a multi-marker gene panel. Mol Oncol 2016;10:1030-42.
26. Francart ME, Lambert J, Vanwynsberghe AM, Thompson EW, Bourcy M, et al. Epithelial-mesenchymal plasticity and circulating tumor
cells: travel companions to metastases. Dev Dyn 2018;247:432-50.
27. Alix-Panabieres C, Mader S, Pantel K. Epithelial-mesenchymal plasticity in circulating tumor cells. J Mol Med (Berl) 2017;95:133-42.
28. Grillet F, Bayet E, Villeronce O, Zappia L, Lagerqvist EL, et al. Circulating tumour cells from patients with colorectal cancer have cancer
stem cell hallmarks in ex vivo culture. Gut 2017;66:1802-10.
29. Zhu P, Fan Z. Cancer stem cells and tumorigenesis. Biophys Rep 2018;4:178-88.
30. Katoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming,
targeted therapy and tumor plasticity (Review). Int J Oncol 2017;51:1357-69.
31. Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev
2018;62:50-60.
32. Sawa M, Masuda M, Yamada T. Targeting the Wnt signaling pathway in colorectal cancer. Expert Opin Ther Targets 2016;20:419-29.
33. Masuda M, Uno Y, Ohbayashi N, Ohata H, Mimata A, et al. TNIK inhibition abrogates colorectal cancer stemness. Nat Commun
2016;7:12586.
34. Begicevic RR, Falasca M. ABC Transporters in cancer stem cells: beyond chemoresistance. Int J Mol Sci 2017;18:2362.
35. Zhang G, Wang Z, Luo W, Jiao H, Wu J, et al. Expression of potential cancer stem cell marker ABCG2 is Associated with malignant
behaviors of hepatocellular carcinoma. Gastroenterol Res Pract 2013;2013:782581.
36. Liu HG, Pan YF, You J, Wang OC, Huang KT, et al. Expression of ABCG2 and its significance in colorectal cancer. Asian Pac J Cancer Prev
2010;11:845-8.
37. Wang X, Xia B, Liang Y, Peng L, Wang Z, et al. Membranous ABCG2 expression in colorectal cancer independently correlates with
shortened patient survival. Cancer Biomark 2013;13:81-8.
38. Ma S, Chan KW, Hu L, Lee TK, Wo JY, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
Gastroenterology 2007;132:2542-56.
39. Zhao W, Ji X, Zhang F, Li L, Ma L. Embryonic stem cell markers. Molecules 2012;17:6196-236.
40. Hang D, Dong HC, Ning T, Dong B, Hou DL, et al. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal
squamous cell carcinoma. Dis Esophagus 2012;25:638-44.
41. Barron GA, Moseley H, Woods JA. Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition. J
Photochem Photobiol B 2013;126:87-96.
42. Dvorak P, Pesta M, Soucek P. ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer. Tumour
Biol 2017;39:1010428317699800.